期刊文献+

拮抗剂方案IVF获卵6枚并发OHSS1例报道及文献复习

Report and Literature Review of A Case of 6 Follicles Obtained by Antagonist IVF Complicated with OHSS
下载PDF
导出
摘要 目的:探讨辅助生殖技术体外受精(in vitro fertilization,IVF)中卵巢过度刺激综合征(ovarian hyper stimulation syndrome,OHSS)发生的潜在性、多样性,为临床工作中OHSS的诊治提供思路和措施。方法:对西南医科大学附属医院辅助生殖技术部1例拮抗剂方案获卵6枚诱发重度OHSS的患者治疗过程进行分析。结果:患者拮抗剂方案移植后诱发重度OHSS,经过预防感染、保胎、输注人血白蛋白(20 g/d)等扩容对症治疗,现NT检查已通过。结论:OHSS的发生是充满复杂性、潜在性的,临床上需尽早观察和预处理,降低患者并发风险,妥善处理并发症。 Objective:To explore the potential and diversity of ovarian hyper stimulation syndrome(OHSS)in in vitro fertilization(IVF)of assisted reproductive technology,and provide ideas for the diagnosis and treatment of OHSS in clinical work.Method:The treatment process of a patient with severe OHSS induced by 6 follicles obtained from antagonist program in department of Assisted Reproductive Technology,Affiliated Hospital of Southwest Medical University was analyzed.Result:The patient’s antagonist regimen induced severe OHSS after transplantation,and the NT test had been passed after dilatational symptomatic treatment such as infection prevention,fetal preservation,infusion of human albumin(20 g/d).Conclusion:The occurrence of OHSS is full of complexity and potential,so early observation and pretreatment are needed in clinical practice to reduce the risk of patients and properly handle complications.
作者 兰云竹 刘玲 黄桂英 LAN Yunzhu;LIU Ling;HUANG Guiying(Southwest Medical University,Luzhou 644000,China;不详)
出处 《中外医学研究》 2021年第36期27-31,共5页 CHINESE AND FOREIGN MEDICAL RESEARCH
基金 西南医科大学校级基金资助计划项目(西南医大校【2016】217号)。
关键词 辅助生殖技术 拮抗剂方案 卵巢过度刺激综合征 治疗方案 Assisted reproductive technology Antagonist scheme Ovarian hyper stimulation syndrome Treatment scheme
  • 相关文献

参考文献7

二级参考文献39

  • 1Al-Inany HG, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conceptionEDB:. CochraneDatabase Syst Rev, 2001 : 4 : CD001750.
  • 2Orvieto R, Patrizio P. GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate[J/OL]. Reprod Biomed Online, 2013,26 : 4-8.
  • 3Pundir J, Sunkara SK, EI-Toukhy T, et al. Meta-analysis of GnRH antagonist protocols:do they reduce the risk of OHSS in PCOS? [J/OL]. Reprod Biomed Online, 2012,24:6-22.
  • 4Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [ EB/OL] . The Cochrane Collaboration 2011. http://hand book cohrane. org/.
  • 5Albano C,Felberbaum RE,Smitz J, et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH- agonist buserelin. European Cetrorelix Study Group [J]. Hum Reprod, 2000,15 : 526-531.
  • 6The European Orgalutran Study Group, Borm G, Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarianstimulation with recombinant follicle stimulating hormoneis effective, safe and convenient: results of a controlled, randomized, multieentre trial[J]. Hum Reprod,2000,15 : 1490-1498.
  • 7Olivennes F, Belaiseh-Allart, Emperare J, et al. Prospective randomized,controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone(LHRH)antagonist(cetrorelix)or a depot formula of an LHRH agonist (triptorelin) [ J ]. Fertil Steril, 2000, 73 : 314-320.
  • 8European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation[J]. Hum Reprod: 2001,16 ; 644-651.
  • 9Fluker M,Grifo J,Leader A, et al. North American Ganirelix Study Group. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulationFJ:. Fertil Steril, 200 i, 75 : 38-45.
  • 10Hohmann FP, Macklon NS, Fauser BC. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone ( GnRH ) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol[J]. J Clin Endocrinol Metab,2003,88 : 166-173.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部